Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients.

Abstract

BACKGROUND:

The presence of significant liver fibrosis in hepatitis B virus (HBV)-infected individuals with persistently normal serum alanine aminotransferase (PNALT) levels is a strong indicator for initiating antiviral therapy. Serum ceruloplasmin (CP) is negatively correlated with liver fibrosis in HBV-infected individuals.

AIM:

To examine the potential value of serum CP and develop a noninvasive index including CP to assess significant fibrosis among HBV-infected individuals with PNALT.

METHODS:

Two hundred and seventy-five HBV-infected individuals with PNALT were retrospectively evaluated. The association between CP and fibrotic stages was statistically analyzed. A predictive index including CP [Ceruloplasmin hepatitis B virus (CPHBV)] was constructed to predict significant fibrosis and compared to previously reported models.

RESULTS:

Serum CP had an inverse correlation with liver fibrosis (r = -0.600). Using CP, the areas under the curves (AUCs) to predict significant fibrosis, advanced fibrosis, and cirrhosis were 0.774, 0.812, and 0.853, respectively. The CPHBV model was developed using CP, platelets (PLT), and HBsAg levels to predict significant fibrosis. The AUCs of this model to predict significant fibrosis, advanced fibrosis, and cirrhosis were 0.842, 0.920, and 0.904, respectively. CPHBV was superior to previous models like the aspartate aminotransferase (AST)-to-PLT ratio index, Fibrosis-4 score, gamma-glutamyl transpeptidase-to-PLT ratio, Forn's score, and S-index in predicting significant fibrosis in HBV-infected individuals with PNALT.

CONCLUSION:

CPHBV could accurately predict liver fibrosis in HBV-infected individuals with PNALT. Therefore, CPHBV can be a valuable tool for antiviral treatment decisions.

• Authors: Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng
• Journal: World journal of gastroenterology (World J Gastroenterol) Vol. 26 Issue 27 Pg. 3952-3962 (Jul 21 2020) ISSN: 2219-2840 [Electronic] United States
• PMID: 32774069 (Publication Type: Journal Article)
• Copyright: ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Chemical References

• Biomarkers
• Ceruloplasmin
• Alanine Transaminase

Topics

• Adult
• Alanine Transaminase
• Biomarkers
• Ceruloplasmin (analysis)
• Female
• Hepatitis B virus
• Hepatitis B, Chronic (complications, diagnosis, pathology)
• Humans
• Liver (pathology)
• Liver Cirrhosis (diagnosis, pathology)
• Male
• Middle Aged
• ROC Curve
• Retrospective Studies